Journal for ImmunoTherapy of Cancer (Nov 2023)
442-C A best-in-class HSC-derived CAR-Monocyte product with a novel CAR costimulatory domain significantly improves CAR-M activity against solid tumors
Abstract
No abstracts available.
Journal for ImmunoTherapy of Cancer (Nov 2023)